These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33768656)

  • 41. Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis.
    Evans JD; Morris PJ; Knight SR
    Am J Transplant; 2014 Dec; 14(12):2765-76. PubMed ID: 25395336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles.
    Hong JY; Kang CI; Yang J; Ko JH; Huh K; Cho SY; Chung DR; Jung CW; Peck KR
    Med Mycol; 2023 Apr; 61(5):. PubMed ID: 37120735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
    Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
    J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
    Miguélez M; Lumbreras C; Herrero JA; Aguado JM; del Palacio A; Colina F; Gómez R; Lizasoain M; Moreno E; Rodríguez-Noriega A
    Med Clin (Barc); 1998 Mar; 110(11):406-10. PubMed ID: 9608495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis.
    Chong PP; Kennedy CC; Hathcock MA; Kremers WK; Razonable RR
    Clin Transplant; 2015 Apr; 29(4):311-8. PubMed ID: 25604399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy: A Multicenter, Prospective, Observational Study in China.
    Wang L; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
    Medicine (Baltimore); 2016 Jan; 95(4):e2560. PubMed ID: 26825897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation].
    Cai CJ; Yi SH; Guo Y; Li MR; Yi HM; Yang Y; Lu MQ; Chen GH
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):911-3. PubMed ID: 18261273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Secondary prophylaxis of invasive fungal infection in haematopoietic stem cell recipients].
    Xu LP; Tang FF; Liu DH; Liu KY; Chen H; Chen YH; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):853-6. PubMed ID: 20079230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.
    Leonart LP; Tonin FS; Ferreira VL; Penteado STS; Wiens A; Motta FA; Pontarolo R
    J Clin Pharm Ther; 2017 Oct; 42(5):530-538. PubMed ID: 28620958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of invasive fungal infections in lung transplant recipients in Western Australia.
    Chang A; Musk M; Lavender M; Wrobel J; Yaw MC; Lawrence S; Chirayath S; Boan P
    Transpl Infect Dis; 2019 Jun; 21(3):e13085. PubMed ID: 30925010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
    Rausch CR; DiPippo AJ; Jiang Y; DiNardo CD; Kadia T; Maiti A; Montalban-Bravo G; Ravandi F; Kontoyiannis DP
    Clin Infect Dis; 2022 Oct; 75(9):1503-1510. PubMed ID: 35325094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose weekly liposomal amphotericin b antifungal prophylaxis in patients undergoing liver transplantation: a prospective phase II trial.
    Giannella M; Ercolani G; Cristini F; Morelli M; Bartoletti M; Bertuzzo V; Tedeschi S; Faenza S; Puggioli C; Lewis RE; Pinna AD; Viale P
    Transplantation; 2015 Apr; 99(4):848-54. PubMed ID: 25531982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
    Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical Characteristics and Risk Factors of Invasive Fungal Infections in Acute Leukemia Patients in Tropical Regions].
    Zheng WS; Guan LX; Wang SY; Hu YL; Peng B; Bo J; Wang QS; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):99-106. PubMed ID: 35123610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.